内容概要:BTK抑制剂是一种新型的靶向抗癌药物,其作用靶点是布鲁顿酪氨酸激酶(BTK),主要是通过对B细胞受体(BCR)信号通路起作用来治疗疾病的。BTK已经成为血液肿瘤治疗领域的核心药物之一。随着对BTK抑制剂在疾病发生发展中作用的深入理解和技术的不断进步,我国BTK抑制剂行业正处于快速发展和变革的时期,市场呈现出巨大增长潜力。2024年,全球BTK抑制剂市场规模增长至120亿美元,较2023年...
Source Link内容概要:BTK抑制剂是一种新型的靶向抗癌药物,其作用靶点是布鲁顿酪氨酸激酶(BTK),主要是通过对B细胞受体(BCR)信号通路起作用来治疗疾病的。BTK已经成为血液肿瘤治疗领域的核心药物之一。随着对BTK抑制剂在疾病发生发展中作用的深入理解和技术的不断进步,我国BTK抑制剂行业正处于快速发展和变革的时期,市场呈现出巨大增长潜力。2024年,全球BTK抑制剂市场规模增长至120亿美元,较2023年...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.